Home LiteratureArticle Details
PMID: 4127020 Published · ppublish English Journal Article

Conversion of the fourth complement component studied by crossed immunoelectrophoresis.

Clinical and experimental immunology ·Vol. 14 ·No. 4 ·1973-08-00 ·Pages 515-29

Sjöholm AG, Laurell AB

Abstract

暂无摘要

MeSH Terms
Aminocaproates Animals Aprotinin Barbiturates Beta-Globulins/analysis Blood Preservation Calcium Carrageenan Cattle Chromatography, DEAE-Cellulose Chymotrypsin Complement Inactivator Proteins Complement System Proteins/analysis,isolation & purification Edetic Acid Factor XII Fibrinolysin Freezing Heparin Humans Immunoelectrophoresis Protein Binding Thrombin Trypsin Trypsin Inhibitors
Chemicals
Aminocaproates Barbiturates Beta-Globulins Complement Inactivator Proteins Trypsin Inhibitors Carrageenan Factor XII Heparin Complement System Proteins Aprotinin Edetic Acid Chymotrypsin Trypsin Thrombin Fibrinolysin Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sjöholm A G
Laurell A B
References (28)
28 references, click to expand
  1. Assay and properties of serum inhibitor of C'l-esterase.
    Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608-11 PMID: 14416422
  2. THE INTERACTION BETWEEN CARRAGEENAN AND THE FIRST COMPONENT OF COMPLEMENT.
    J Immunol. 1965 May;94:662-6 PMID: 14296284
  3. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.
    J Exp Med. 1969 Feb 1;129(2):315-31 PMID: 4178758
  4. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.
    J Immunol. 1964 Mar;92:456-67 PMID: 14128991
  5. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
    J Lab Clin Med. 1970 Nov;76(5):809-15 PMID: 5477337
  6. [Fibrin agar electrophoresis. 1. Description of the method].
    Thromb Diath Haemorrh. 1962 Jul 15;7:432-43 PMID: 13906033
  7. [In vitro studies on the mode of action and differences to heparin. Anticomplementary effect of a semisynthetic pentosan-polysulfo-ester].
    Z Naturforsch B. 1971 May;26(5):403-8 PMID: 4398277
  8. Effect of inhibitors on kinin-releasing activity of proteases.
    Fed Proc. 1968 Jan-Feb;27(1):96-9 PMID: 4283639
  9. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 May 1;121:819-33 PMID: 14280442
  10. Studies on the role of Ca++ and Mg++ in complement fixation and immune hemolysis. III. The respective roles of Ca++ and Mg++ in immune hemolysis.
    J Immunol. 1953 Nov;71(5):374-9 PMID: 13118175
  11. The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r.
    J Exp Med. 1968 Oct 1;128(4):571-93 PMID: 5675434
  12. C1 inactivator protein complexed with albumin in plasma from a patient with angioneurotic edema.
    Eur J Immunol. 1971 Apr;1(2):146-9 PMID: 5127392
  13. Some properties of an esterase derived from preparations of the first component of complement.
    J Exp Med. 1957 Aug 1;106(2):327-43 PMID: 13449241
  14. Cleavage of the fourth component of human complement (C4) by C1 esterase: isolation and characteristics of the low molecular weight product.
    Immunochemistry. 1970 Feb;7(2):227-34 PMID: 5442809
  15. INHIBITION OF THE C'-1 COMPONENT OF COMPLEMENT BY AMINO ACIDS.
    Immunology. 1964 Jul;7:319-31 PMID: 14193148
  16. Chromatographic resolution of the first component of human complement into three activities.
    J Exp Med. 1963 Jun 1;117:983-1008 PMID: 13929797
  17. Activation of the first component of complement evidence for an internal activation step.
    J Immunol. 1972 Mar;108(3):683-8 PMID: 5011751
  18. The separation of nine components and two inactivators of components of complement in humansserum.
    Immunochemistry. 1970 Jan;7(1):43-61 PMID: 5416393
  19. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
    Anal Biochem. 1965 Feb;10:358-61 PMID: 14302464
  20. The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.
    J Clin Invest. 1965 Feb;44(2):302-14 PMID: 16695912
  21. Comparison between a direct and an indirect method for determining plasminogen.
    Thromb Diath Haemorrh. 1971 Oct 31;26(2):289-94 PMID: 5134482
  22. Quantitation of the fourth complement component by electrophoresis in agarose gel containing antibodies.
    Clin Exp Immunol. 1970 Sep;7(3):423-30 PMID: 4991123
  23. Studies on the activation of a proesterase associated with partially purified first component of human complement.
    J Exp Med. 1958 Mar 1;107(3):451-74 PMID: 13513912
  24. Structural polymorphism of the fourth component of human complement.
    J Clin Invest. 1969 Dec;48(12):2283-92 PMID: 5389795
  25. Preparation of complement reagents by means of gel filtration.
    Acta Pathol Microbiol Scand. 1962;54:439-48 PMID: 13893396
  26. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968.
    Thromb Diath Haemorrh. 1969 Apr 30;21(2):259-72 PMID: 4238780
  27. Inability of a highly purified streptokinase preparation to inactivate complement in serum.
    Acta Pathol Microbiol Scand. 1965;64(3):318-28 PMID: 5855583
  28. Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro.
    J Exp Med. 1968 Mar 1;127(3):411-29 PMID: 5299945
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
1973-08-00
Pages
515-29
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1553814
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]